Back
ProShares Ultra Consumer Discretionary Vs. Corcept Therapeutics Industry Stock Comparison
Buy
72
UCC
ProShares Ultra Consumer Discretionary
Last Price:
40.68
Seasonality Move:
3%
Buy
74
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Buy
72
ProShares Ultra Consumer Discretionary (UCC)
is a Buy
Is ProShares Ultra Consumer Discretionary a Buy, Sell or Hold?
- The current ProShares Ultra Consumer Discretionary [UCC] share price is $40.79. The Score for UCC is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- UCC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $40.92. The Score for CORT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UCC Stock Price Chart
What is ProShares Ultra Consumer Discretionary's stock price today?
-
The ProShares Ultra Consumer Discretionary share price today is $40.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UCC is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $40.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
UCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 67.66 | Buy |
| Chaikin Money Flow: | 5917 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.65 - 38.47) | Buy |
| Bollinger Bands (100): | (33.58 - 37.92) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.55 | Buy |
| Relative Strength Index (14 RSI): | 72.34 | Buy |
| Chaikin Money Flow: | -986948 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.51 - 37.97) | Buy |
| Bollinger Bands (100): | (28.35 - 36.03) | Buy |
UCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.75 | Buy |
| 20-day SMA: | 37.27 | Buy |
| 50-day SMA: | 36.42 | Buy |
| 200-day SMA: | 35.39 | Buy |
| 8-day EMA: | 38.86 | Buy |
| 20-day EMA: | 37.58 | Buy |
| 50-day EMA: | 36.6 | Buy |
| 200-day EMA: | 34.98 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.22 | Buy |
| 20-day SMA: | 36.07 | Buy |
| 50-day SMA: | 35.08 | Buy |
| 200-day SMA: | 28.51 | Buy |
| 8-day EMA: | 38.83 | Buy |
| 20-day EMA: | 36.86 | Buy |
| 50-day EMA: | 34.93 | Buy |
| 200-day EMA: | 30.16 | Buy |
ProShares Ultra Consumer Discretionary Earnings Growth & UCC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
ProShares Ultra Consumer Discretionary Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||